Business
Mata Mata Turtle with Squamous Cell Carcinoma Successfully Treated with Sensus Healthcare’s SRT System by Colorado State University Veterinarian
Joins multiple companion animals and a horse successfully treated with SRT BOCA RATON, Fla. , March 24, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc.
About this update from Sensus Healthcare, Inc.
[{"type":"text","content":"Joins multiple companion animals and a horse successfully treated with SRT\nBOCA RATON, Fla. , March 24, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that a mata mata turtle has joined the growing list of animal species successfully treated with Sensus Healthcare’s SRT-100 system. Tiffany Martin, DVM, MS, Assistant Professor, Radiation Oncology at Colorado State University Veterinary Teaching Hospital applied superficial radiation therapy (SRT) to the turtle’s squamous cell carcinoma in June 2021. The female turtle, which resides at Denver Zoo, showed no signs of the lesion three months after therapy, and continues to be cancer-free as of today. In March 2021 Sensus announced that the first animal, a canine, had been treated at the Flint Animal Cancer Center at the Colorado State (CSU) James L. Voss Veterinary Teaching Hospital. Sensus has an agreement with CSU for developing protocols for SRT use and publishing clinical data. Dr. Martin has used SRT to treat a variety of tumor types including three squamous cell carcinomas, three mast cell tumors, two plasma cell tumors and two soft tissue sarcomas in 12 animals, including five dogs, five cats, a horse and the turtle. Dr. Martin said, “We are delighted to continue deploying the Sensus Healthcare device to investigate treatment protocols for a range of animals and conditions, and note that our successes thus far merit continued research. I have previously commented on the utility of this device in small or unreachable tumors compared with traditional radiation therapies. Our early work suggests that Sensus’ SRT system may play an important role in veterinary medicine. The Sensus SRT system gives us an opportunity to treat patients in a way that we have not been able to before.” “Our partnership with CSU has been highly gratifying while also opening a potential new market for our SRT system,” said John Heinrich, Ph.D., a member of the Sensus Healthcare board of directors and the key relationship contact with CSU. “We are thrilled that Denver Zoo entrusted Dr. Martin and the use of SRT in the care of their animal, and that the procedure was so successful. We look forward to providing ...